The Defence Research and Development Organisation is an agency of the Government of India, charged with the military's research and development, headquartered in New Delhi, India. Read More
The DRDO's new anti-COVID drug, 2-DG, reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the union health ministry informed on Monday. ...
The DRDO's new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy's labs. ...
The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said on Monday. ...
After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh here, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need. While the drug shall be made ava ...
After releasing the first batch of anti-COVID drug 2-DG developed by the Defence Research and Development Organisation (DRDO), Defence Minister Rajnath Singh on Monday termed the drug as a new ray of hope and said this is a great example of India's s ...
Defence Minister Rajnath Singh on Monday lauded the Defence Research and Development Organisation (DRDO) for developing 2-deoxy-D-glucose (2-DG) drug for the treatment of COVID-19. ...
Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRD ...
Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO). ...
